Revlimid Prices, Coupons and Patient Assistance Programs
Revlimid (lenalidomide) is a member of the miscellaneous antineoplastics drug class and is commonly used for Anemia, Follicular Lymphoma, Lymphoma, and others.
This Revlimid price guide is based on using the U.S. pharmacies. The cost for Revlimid oral capsule 2.5 mg is around $22,314 for a supply of 28 capsules, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Revlimid is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Revlimid availability.
Recommended Dosage for Multiple Myeloma
REVLIMID Combination Therapy
The recommended starting dose of REVLIMID is 25 mg orally once daily on Days 1-21 of repeated 28-day cycles in combination with dexamethasone. Refer to Section 14.1 for specific dexamethasone dosing. For patients greater than 75 years old, the starting dose of dexamethasone may be reduced [see Clinical Studies (14.1)]. Treatment should be continued until disease progression or unacceptable toxicity.
In patients who are not eligible for auto-HSCT, treatment should continue until disease progression or unacceptable toxicity. For patients who are auto-HSCT-eligible, hematopoietic stem cell mobilization should occur within 4 cycles of a REVLIMID-containing therapy [see Warnings and Precautions (5.12)].
Dose Adjustments for Hematologic Toxicities During MM Treatment
Dose modification guidelines, as summarized in Table 1 below, are recommended to manage Grade 3 or 4 neutropenia or thrombocytopenia or other Grade 3 or 4 toxicity judged to be related to REVLIMID.